Medisch oncoloog Patricia Soetekouw van Maastricht UMC+ vertelt in het programma L1 Laat over de ontwikkeling van het combinatiemedicijn dat kankergroei remt. Hoewel het geneesmiddel nog in onderzoeksfase is, ziet de toekomst er hoopvol uit.
Maastricht UMC+ offers Google® Translate as a convenience for visitors to our web site who may not have Dutch as their primary language. Google® Translate provides automated translations, which may result in incorrect or misleading translations. Maastricht UMC+ is not responsible for any translations provided by Google® Translate or for any damages or losses arising from the use of or reliance on these translations. Viewers who rely on information through Google® Translate on our web site do so at their own risk.
